118 related articles for article (PubMed ID: 1413532)
1. [The clinical features of HTLV-I infection. HTLV-I associated myelopathy].
Nakagawa M; Izumo S; Ikurou M; Osame M
Uirusu; 1992 Jun; 42(1):21-8. PubMed ID: 1413532
[No Abstract] [Full Text] [Related]
2. [HTLV-I-associated myelopathy].
Osame M
Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):389-92. PubMed ID: 1607802
[No Abstract] [Full Text] [Related]
3. Tropical spastic paraparesis and HTLV-I myelopathy: clinical features and pathogenesis.
Rodgers-Johnson PE; Ono SG; Asher DM; Gibbs CJ
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():117-30. PubMed ID: 2183307
[No Abstract] [Full Text] [Related]
4. Interferon-alpha treatment in HTLV-I-associated myelopathy. Studies of clinical and immunological aspects.
Shibayama K; Nakamura T; Nagasato K; Shirabe S; Tsujihata M; Nagataki S
J Neurol Sci; 1991 Dec; 106(2):186-92. PubMed ID: 1802967
[TBL] [Abstract][Full Text] [Related]
5. [HTLV-I-associated myelopathy (HAM)].
Osame M
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1320-6. PubMed ID: 2356333
[No Abstract] [Full Text] [Related]
6. [HTLV-I-associated myelopathy].
Osame M
Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):41-5. PubMed ID: 10201131
[No Abstract] [Full Text] [Related]
7. [HAM (HTLV-I associated myelopathy)].
Igata A
Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1726-8. PubMed ID: 2625592
[No Abstract] [Full Text] [Related]
8. Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy.
Kuroda Y; Kurohara K; Fujiyama F; Takashima H; Endo C; Matsui M; Neshige R; Kakigi R
Acta Neurol Scand; 1992 Jul; 86(1):82-6. PubMed ID: 1519481
[TBL] [Abstract][Full Text] [Related]
9. Presence of human T lymphotropic virus type I in two patients with progressive myelopathy in Puerto Rico.
Reyes-Iglesias Y; Melendez-Feliciano R; Garayalde-Cotroneo G
Neurology; 1991 Sep; 41(9):1515-6. PubMed ID: 1891106
[TBL] [Abstract][Full Text] [Related]
10. HTLV seroepidemiology in a central African population with high incidence of tropical spastic paraparesis.
Goubau P; Carton H; Kazadi K; Muya KW; Desmyter J
Trans R Soc Trop Med Hyg; 1990; 84(4):577-9. PubMed ID: 2091355
[TBL] [Abstract][Full Text] [Related]
11. Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii.
Dixon PS; Bodner AJ; Okihiro M; Milbourne A; Diwan A; Nakamura JM
West J Med; 1990 Mar; 152(3):261-7. PubMed ID: 2139754
[TBL] [Abstract][Full Text] [Related]
12. Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews.
Achiron A; Pinhas-Hamiel O; Doll L; Djaldetti R; Chen A; Ziv I; Avni A; Frankel G; Melamed E; Shohat B
Ann Neurol; 1993 Nov; 34(5):670-5. PubMed ID: 8239561
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell lymphotropic virus type I and neurologic disease in Panama, 1985 and 1986.
Gracia F; Reeves WC; Levine PH; Cuevas M; Castillo L; Chavarría R; Grimaldo V; Triana E; Arosemena JR; Blattner WA
Arch Neurol; 1990 Jun; 47(6):634-9. PubMed ID: 2346389
[TBL] [Abstract][Full Text] [Related]
14. Spastic paraparesis of obscure origin. A case-control study of HTLV-I positive and negative patients from Rio de Janeiro, Brazil.
Araújo Ade C; Afonso CR; Schor D; Andrada-Serpa MJ
J Neurol Sci; 1993 Jun; 116(2):165-9. PubMed ID: 8336163
[TBL] [Abstract][Full Text] [Related]
15. Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
Osame M; Nakagawa M; Umehara F; Ijichi S; Moritoyo T; Higuchi I; Usuku K; Arimura K; Izumo S
J Neurovirol; 1997 May; 3 Suppl 1():S50-1. PubMed ID: 9179793
[No Abstract] [Full Text] [Related]
16. HTLV-1 infection and tropical spastic paraparesis in Esmeraldas Province of Ecuador.
Guderian R; Guevara A; Cooper P; Rugeles MT; Arango C
Trans R Soc Trop Med Hyg; 1994; 88(4):399-400. PubMed ID: 7570816
[No Abstract] [Full Text] [Related]
17. Associations among HTLV-I, HTLV-II, and HIV in injecting drug users in Salvador, Brazil.
Andrade TM; Dourado I; Galvão-Castro B
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):186-7. PubMed ID: 9637584
[No Abstract] [Full Text] [Related]
18. HTLV-I associated myelopathy (HAM): review and recent studies.
Osame M; Arimura K; Nakagawa M; Umehara F; Usuku K; Ijichi S
Leukemia; 1997 Apr; 11 Suppl 3():63-4. PubMed ID: 9209299
[No Abstract] [Full Text] [Related]
19. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
20. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.
Araújo Ade Q; Alfonso CR; Schor D; Leite AC; de Andrada-Serpa MJ
Acta Neurol Scand; 1993 Jul; 88(1):59-62. PubMed ID: 8372632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
